Georgia Capital 3Q23 & 9M23 Performance Overview
Private investment
stage portfolio
companies
EXTERNALLY VALUED
&
18
CLINICS & DIAGNOSTICS BUSINESS OVERVIEW (CONT'D)
Community Clinics
Outpatient and basic inpatient
services in regional towns and
municipalities
17
Polyclinics
CLINICS (3Q23)
Outpatient diagnostic and
treatment services in Tbilisi
and major regional cities
c.291,300
Market share by number of registered patients*
632,200
GCAP Clinics
Geo
Hospitals
319,000
22%
Medcapital
136,000
Market share by registered patients Registered patient in Tbilisi
Medison
91,000
c.632,200
Registered patient in Georgia
Other
*As of 30-Sep-23.
NET REVENUE, CLINICS
c.164,000
GEORGIA
CAPITAL
DIAGNOSTICS (3Q23)
Average number of tests per
patient
3.4
Number of patients served
22%
11%
c.560,000
GEL 7.5
5%
Number of tests performed
Average revenue per test
(excluding COVID-19)
3%
16%
1,659,000
59%
Retail portion in total revenue
EBITDA, CLINICS (excl. IFRS 16)
GEL million
Gross profit margin (%)
42.6% 44.8% 46.5% 44.1% 42.4% 41.7% 43.6% 42.4% 43.5%
15.4% 19.9% 20.1% 19.9% 13.5% 8.9% 31.2%
14.8%
19.7%
EBITDA margin (%, excl. IFRS 16)
EBITDA, DIAGNOSTICS (excl. IFRS 16)
EBITDA margin (%, excl. IFRS 16)
3.2% 12.3% 23.8% 3.3% -0.2% 4.2% 5.9% 6.2%
+3.8%
70.5
44.2 46.3 33.3
65.8
24.9
+11.5%
37.8
21.0 21.4
51.1
49.2
18.9 15.8
GEL million
14.1
39.8%
7.3
8.9
9.4
5.9
17.9
19.9
23.2 24.9
37.2
40.9 14.1
5.U
16.1
46
10.3
9.0
NMF
7.4
5.2
1.3
GEL million
-12.4%
NMF
1.8
0.7
1.0 0.8
0.2
30.3
35.3
0.2
0.0
2018 2019
2020 2021 2022 3Q22 3Q23
Polyclinics â– Community Clinics
2019 2020 2021 2022
9M22 9M23
2018
2019
2020
2021
2022 3Q22
3Q23
9M22
9M23
3Q22 3Q23
9M22 9M23
71View entire presentation